Skip to content

Drug interactions

Paclitaxel + Siponimod

Severity: Moderate

Paclitaxel and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Paclitaxel commonly causes neutropenia, and siponimod lowers lymphocytes, so infection risk may be increased. Paclitaxel is also a CYP2C8 substrate, which has minor relevance to siponimod metabolism via CYP2C9.

What this interaction means in plain words

Paclitaxel and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Paclitaxel belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive pharmacodynamic effects: chemotherapy-induced myelosuppression plus S1P-mediated lymphocyte reduction.

What to do

Monitor complete blood counts and for infection during co-therapy. Consider holding siponimod if severe neutropenia or lymphopenia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Paclitaxel and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Paclitaxel with Siponimod?

MediHelp rates the interaction as moderate. Paclitaxel and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Paclitaxel commonly causes neutropenia, and siponimod lowers lymphocytes, so infection risk may be increased. Paclitaxel is also a CYP2C8 substrate, which has minor relevance to siponimod metabolism via CYP2C9.

How serious is the interaction between Paclitaxel and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts and for infection during co-therapy. Consider holding siponimod if severe neutropenia or lymphopenia occurs.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in